Top Markets
#1 GEKKO GEKKO +52.86%
#2 Helium Helium +48.09%
#3 Pons Pons +25.55%
#4 Main Street Yield Main Street Yield +17.48%
#5 龙虾 (Lobster) 龙虾 (Lobster) +15.91%
#6 Collect on Fanable Collect on Fanable +14.24%
#7 o1.exchange o1.exchange +12.13%
#8 Ontology Gas Ontology Gas +11.63%
#9 Nockchain Nockchain +11.47%
#10 OpenGradient OpenGradient +10.61%
Coin of the day
GEKKO GEKKO
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Daan Gene Co., Ltd. Daan Gene Co., Ltd.

Daan Gene Co., Ltd.

002030
Clasificación en acciones #8888
Daan Gene Co., Ltd. specializes in the research, development, manufacturing,... Daan Gene Co., Ltd. specializes in the research, development, manufacturing, and commercialization of clinical diagnostic reagents and instruments. The company's extensive product portfolio encompasses advanced solutions such as fluorescence quantitative PCR products, time-resolved series diagnostics, enzyme-linked immunoassay (EIA) kits, various diagnostic instruments, and specialized scientific research services. Beyond product offerings, the company extends its expertise to provide comprehensive medical examination and health management services. These encompass a wide range of offerings, from genetic susceptibility gene testing and tumor marker analysis to crucial cervical cancer screening and general routine physical examinations, alongside other personalized health support. Established in 2001, the company was originally known as Da An Gene Co., Ltd. of Sun Yat-Sen University. It is presently headquartered in Guangzhou, located in the People's Republic of China.
Precio por acción
$0.81586517
Última sincronización: 2026-08-28
Capitalización bursátil
$1.15B
Cambio (1 día)
0.18%
Cambio (1 año)
-13.81%
País
CN
Comercio Daan Gene Co., Ltd. (002030)

Categoría

Healthcare
Ingresos de Daan Gene Co., Ltd. (002030)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de Daan Gene Co., Ltd., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de Daan Gene Co., Ltd. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH